Biotechnology stocks and sector-related exchange traded funds stood out on Tuesday after a U.S. District Court overruled President Donald Trump’s wishes to require drugmakers list prices on television advertisements. Among the better performers on Tuesday, the SPDR S&P Biotech ETF...